Patients treated (%)
|
347 (100)
|
311 (89)
| |
Appropriate ATB decision
b
(%)
|
253 (73)
|
278 (80)
|
0.02d
|
No ATB, negative UCc
|
0
|
31
|
ATB, positive UC
|
253
|
247
|
Inappropriate ATB decision (%)
|
94 (27%)
|
70 (20%)
|
ATB, negative UC
|
94
|
64
|
No ATB, positive UC
|
0
|
6
| |
Overall susceptibility rates according to the ATB regimen
e
(%)
| | | |
Fosfomycin
|
89
|
90
|
Nitrofurantoin
|
98
|
98
|
TMP-SMX
|
85
|
86
|
Ofloxacin
|
94
|
95
|
Pivmecillinam
|
76
|
78
|
Fosfomycin, except if RUT-
| | |
For nitrites and age < 30: nitrofurantoin
| |
93
|
Fosfomycin, except if RUT-
| | |
For nitrites and age < 30: ofloxacin
| |
93
|